← Back to patent-cliff list

CAS 22288-78-4

Methyl 3-aminothiophene-2-carboxylatemethyl 3-aminothiophene-2-carboxylate

Codes: OLMU-001, BEBT-908-001, FIMEP-001

Application context (from source-drug indications)

Non-small cell lung cancerOlmutinibDiffuse large B-cell lymphomaIfupinostat Hydrochloride大B细胞淋巴瘤Ifupinostat HydrochloridePeripheral T-cell lymphomaIfupinostat HydrochlorideNon-small cell lung cancerIfupinostat HydrochlorideBreast cancerIfupinostat HydrochlorideMetastatic breast cancerIfupinostat HydrochlorideCushing's syndromeFimepinostatGliomaFimepinostatGlioblastomaFimepinostatDiffuse intrinsic pontine gliomaFimepinostat髓母细胞瘤Fimepinostat星形细胞瘤Fimepinostat

Source drugs (routes using this intermediate)

DrugTierExpiry
OlmutinibTier C — Watch / trade-
Ifupinostat HydrochlorideTier C — Watch / trade-
FimepinostatTier C — Watch / trade-

Position in synthesis routes (up/downstream chain)

Ordered by route registration; left → right is the synthesis direction. The highlighted node is the current CAS; others link to their own profiles.

Intermediates available on this site

No listed intermediates for this target yet — send an RFQ directly and it will enter our matching pool.

This is a CAS-level registry record: registrations across routes are merged. Supplier offers and buyer demands will be matched on this CAS as the primary key.